On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
On Jan. 26, 2023, the U.S. Food and Drug Administration revised the Emergency Use Authorization for Evusheld (tixagevimab…
On Jan. 26, 2023, Twist Bioscience announced that it had begun offering high-quality synthetic DNA using its silicon…
On Jan. 26, 2023, Centers for Disease Control and Prevention (CDC) reported that U.S. household spread of flu…
On Jan. 25, 2023, Roche and its subsidiary TIB Molbiol announced they had developed a COVID-19 PCR test…
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
On Jan. 25, 2023, researchers at Oregon Health & Science University (OHSU) reported that Immunity from COVID-19 appears…
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Jan. 19, 2023, researchers at ETH Zurich and the Swiss Federal research institute WSL announced they had…
On Jan. 18, 2023, Novavax announced that partner SK bioscience had received expanded manufacturing and marketing approval from…
On Jan. 18, 2023, the National Institutes of Health (NIH) announced that an investigational HIV vaccine regimen tested…
On Jan. 18, 2023, researchers at the U.S. Department of Agriculture’s Agricultural Research Service announced they had bred…
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
On Jan. 17, 2023, the Montana Fish and Wildlife Commission (FWP) reported that juvenile grizzly bears tested positive…
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
On Jan. 11, 2023, Roche announced treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. Post-exposure prophylaxis…
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
On Jan. 10, 2023, the U.S. National Institutes of Health (NIH) reported that antiviral treatments can help reduce…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
On Jan. 6, 2023, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Jan. 5, 2023, the National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and…
On Jan. 5, 2023, National Institutes of Health researchers announded they had published an assessment of 13 studies…
On Jan. 5, 2023, Novavax announced that Spain’s Public Health Commission, Italy’s Ministry of Health, and France’s Haute…
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…